Aspects of the Global Platform for Access to Childhood Cancer Medicines at World Cancer Congress – St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital posted on LinkedIn:

“Delivering quality-assured cancer medicines to low- and middle-income countries presents many challenges and requires collaborative efforts by a wide variety of experts around the world. At the World Cancer Congress in Geneva this week, Carlos Rodriguez-Galindo, Chair, St. Jude Department of Pediatric Medicine, and Director of St. Jude Global, led a session discussing these aspects of the Global Platform for Access to Childhood Cancer Medicines.

Other speakers in the session include delegates from WHO, UNICEF and PAHO, as well as representatives from Zambia, Mongolia and Ecuador who will discuss their roles in addressing the challenges of delivering quality medicines effectively in low- and middle-income countries.

The collaborative Global Platform for Access to Childhood Cancer Medicines initiative was created by St. Jude and World Health Organization to provide an uninterrupted supply of medicines to low- and middle-income countries for the treatment of childhood cancer. The challenges of availability, quality and cost are different in each country and forming unified efforts to address those challenges between the institutions, governments, the pharmaceutical industry, nongovernmental organizations and the nonprofit sector is key to establishing effectiveness for the Global Platform.

In other sessions, Catherine Lam discussed understanding and addressing childhood cancer disparities between high-income and low-income countries; and Michael McNeil discussed a model of education and training to advance global integration of Pediatric Palliative Care.”

Source: St. Jude Children’s Research Hospital/LinkedIn